High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: Clinical review
Harry Openshaw(City Of Hope National Medical Center), Peter A. McSweeney(Mesoblast (United States)), Richard A. Nash(Colorado Blood Cancer Institute)
Cited by 45
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k